Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvularn         heart disease

Gilbert Habib

首页> 外文期刊>European Journal of Echocardiography >Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvularn heart disease

【24h】

Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvularn heart disease

机译：与Benfluorex疗法相关的瓣膜性心脏病：原因不明的限制性瓣膜性心脏病患者的高患病率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Echocardiography》 |2011年第9期|p.688-695|共8页
作者
Gilbert Habib;
展开▼
作者单位

, la Timone Hospital Marseille France, @%@Corresponding author. Tel: +33 491 387 588, Email:;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease. [J] . Boudes A, Lavoute C, Avierinos JF, European journal of echocardiography: the journal of the Working Group on Echocardiography of the European Society of Cardiology . 2011,第9期

机译：与Benfluorex疗法相关的瓣膜性心脏病：原因不明的限制性瓣膜性心脏病的患病率较高。
2. Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. [J] . Boriani G, Gasparini M, Landolina M European Heart Journal: The Journal of the European Society of Cardiology . 2009,第18期

机译：心脏再同步治疗对患有瓣膜性心脏病的心力衰竭患者的有效性：与缺血性心脏病或扩张型心肌病患者的比较。 InSync / InSync ICD意大利语注册表。
3. Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry [J] . Giuseppe Boriani1* Maurizio Gasparini2 Maurizio Landolina3 Maurizio Lunati4 Mauro Biffi1 Massimo Santini5 Luigi Padeletti6 Giulio Molon7 Gianluca Botto8 Tiziana De Santo9 and Sergio Valsecchi9 on behalf of the InSync/InSync ICD Italian Registry Investigators European Heart Journal . 2009,第18期

机译：心脏再同步治疗在瓣膜性心脏病心力衰竭患者中的有效性：与缺血性心脏病或扩张型心肌病患者的比较。 InSync / InSync ICD意大利语注册表
4. Clinical Efficacies of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Heart Failure Due to Valvular and Non-Valvular Heart Disease [C] . Jing Bai, Yan Wang 2019 International Conference on Biology, Chemistry and Medical Engineering（ 2019年国际生物、化学和医学工程会议（ICBCME 2019）论文集 . -1

机译：重组人脑利钠肽在瓣膜和非瓣膜心脏病患者治疗心力衰竭患者中的临床疗效
5. The Effectiveness of a Heart Failure Disease Management Programme on Clinical Outcomes, Health-related Quality of Life, and Psychological Status of Patients with Heart Failure in China. [D] . Yu, Mingming. 2011

机译：心力衰竭疾病管理计划对中国心力衰竭患者的临床结果，健康相关生活质量和心理状况的有效性。
6. Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study [O] . Irène Frachon, Yves Etienne, Yannick Jobic, 2010

机译：Benfluorex和无法解释的瓣膜性心脏病：病例对照研究
7. ACC/AHA guidelines for the management of patients with valvular heart disease A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on management of patients with valvular heart disease)11When citing this document, the American College of Cardiology and the American Heart Association recommend that the following format be used: Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O’Gara PT, O’Rourke RA, Rahimtoola SH. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Am Coll Cardiol.1998;32:1486–588.22Address for reprints: A single reprint of this document (the complete Guidelines) is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0153. To obtain a reprint of the shorter version (Executive Summary and Summary of Recommendations) published in the November 3 issue of Circulation, ask for reprint No. 71-0154. To purchase additional reprints, specify version and reprint number: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail pubauth@heart.org [O] . Bonow RobertO., Carabello Blase, de Leon AntonioC., 1998

机译：ACC / AHA瓣膜性心脏病患者治疗指南美国心脏病学会/美国心脏协会工作组实践指南（瓣膜性心脏病患者治疗委员会）的报告11引用本文件时，美国心脏病学会心脏病学和美国心脏协会建议使用以下格式：Bonow RO，Carabello B，de Leon AC Jr，Edmunds LH Jr，Fedderly BJ，Freed MD，Gaasch WH，McKay CR，Nishimura RA，O'Gara PT，O 'Rourke RA，Rahimtoola SH。 ACC / AHA瓣膜性心脏病患者治疗指南：美国心脏病学会/美国心脏协会实践指南工作组（瓣膜性心脏病患者治疗委员会）的报告。 J Am Coll Cardiol.1998; 32：1486–588.22转载地址：可致电800-253-4636（仅美国）或写信给美国心脏病学会教育服务部，获得本文件的单一转载（完整的准则）。，9111 Old Georgetown Road，Bethesda，MD 20814-1699。要求转载第71-0153号。要获得11月3日发行的Circulation的较短版本（执行摘要和建议摘要）的重印本，请索要第71-0154号重印本。要购买其他重印本，请指定版本和重印编号：最多999份，请致电800-611-6083（仅限美国）或传真413-665-2671；否则请重新发送。 1000或更多副本，请致电214-706-1466，传真214-691-6342或电子邮件pubauth@heart.org

Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvularn heart disease

著录项

相似文献

相关主题

期刊订阅